Dr. Abud Bakri

They might be using some of these peptide stimulants, some Axolank, whatever it may be.

So the question, because what happens is people go to these websites, they buy one peptide, and they got a great result.

And they'll be like, you know, let me add three more peptides on.

It's an increasing AOV problem.

So the average sale value goes up from these research sites.

We'll see where GLP-1s go.

The reality is it's here.

There is no pre-GLP-1 world for us as clinicians, as health enthusiasts.

We're in a post-GLP-1 world and everything kind of dictates downstream from that.

Yeah, well, leptin sensitivity increases as you decrease the body fat mass.

There's GLP-1 receptors on the POMC neurons in the brain.

And no one's kind of examined what that means downstream for the leptin-melanocortin pathway and what that means for energy status, thyroid hormone production, reproductive status.

We know a lot of people are ozembic babies and that a lady will be subfertile or infertile, start a weight loss drug, and then find out by accident she's pregnant.

Was she obese before?

Yeah, these are overweight, obese women that are having their fertility improve as a result of losing the weight.

Because we know your leptin status is a key driver of fertility.

Because if you're having low leptin levels, you're starving, you shouldn't be fertile.

If you have too much leptin and your leptin

resistant, you shouldn't be having kids either.

So both of those things kind of get modulated by these drugs as well.